These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7751162)

  • 1. The T-cell receptor V beta 6 gene usage in alloreactive T-cell responses.
    Hu W; Weyand CM; Goronzy JJ
    Hum Immunol; 1995 Jan; 42(1):72-80. PubMed ID: 7751162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restrictions in the repertoire of allospecific T cells. Contribution of the alpha-helical sequence polymorphism of HLA-DR molecules.
    Goronzy JJ; Xie C; Hu W; Lundy SK; Weyand CM
    J Immunol; 1993 Jul; 151(2):825-36. PubMed ID: 8335912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective T cell receptor Vbeta gene usage by alloreactive T cells responding to defined HLA-DR alleles.
    Lobashevsky A; Kotb M; Gaber AO
    Transplantation; 1996 Nov; 62(9):1332-40. PubMed ID: 8932281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of T cell receptor V beta elements by HLA-DR determinants predisposing to rheumatoid arthritis.
    Weyand CM; Oppitz U; Hicok K; Goronzy JJ
    Arthritis Rheum; 1992 Sep; 35(9):990-8. PubMed ID: 1384516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DRB1 molecules and antigenic experience shape the repertoire of CD4 T cells.
    Walser-Kuntz DR; Weyand CM; Fulbright JW; Moore SB; Goronzy JJ
    Hum Immunol; 1995 Dec; 44(4):203-9. PubMed ID: 8770633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell expansions with conserved T-cell receptor beta chain motifs in the peripheral blood of HLA-DRB1*0401 positive patients with necrotizing vasculitis.
    Grunewald J; Halapi E; Wahlström J; Giscombe R; Nityanand S; Sanjeevi C; Lefvert AK
    Blood; 1998 Nov; 92(10):3737-44. PubMed ID: 9808568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonrandom selection of T cell specificities in anti-HLA-DR responses. Sequence motifs of the responder HLA-DR allele influence T cell recruitment.
    Weyand CM; Hicok KC; Goronzy JJ
    J Immunol; 1991 Jul; 147(1):70-8. PubMed ID: 2051028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of TCR-alpha beta sequences of cross-reactive anti-DR alloreactive T-cell clones: identification of possible contact residues based on charge complementarity between TCR chains and DR determinants.
    Champagne E; Essaket S; Huchenq A; Fabron J; Coppin HL; Sevin J; Thomsen M
    Eur J Immunogenet; 1992; 19(1-2):21-31. PubMed ID: 1533151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonrandom T cell receptor usage in the allorecognition of HLA-DR1 microvariation.
    Hurley CK; Steiner N; Wagner A; Geiger MJ; Eckels DD; Rosen-Bronson S
    J Immunol; 1993 Feb; 150(4):1314-24. PubMed ID: 8381833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DRB1 amino acid disparity is the major stimulus of interleukin-2 production by alloreactive helper T-lymphocytes.
    Young NT; Roelen DL; Dallman MJ; Morris PJ; Welsh KI
    Immunogenetics; 1998 Mar; 47(4):310-7. PubMed ID: 9472067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allorecognition and T cell repertoire selection in severe combined immunodeficiency lacking HLA class II antigens.
    Knobloch C; Ballas M; Wölpl A; Friedrich W
    Transplantation; 1992 Jun; 53(6):1295-301. PubMed ID: 1534939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell receptor diversity expressed by CD4+ T cells activated by primary allogeneic HLA-DR stimulation: estimation of the degree of CDR3 diversity.
    Onda K; Kashiwagi N; Obata F
    Scand J Immunol; 1996 May; 43(5):519-24. PubMed ID: 8633209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the T-cell receptors utilized for allogeneic HLA-DR recognition: comparison of different responder-cell donors possessing an identical HLA-DR allele.
    Obata F; Tsunoda-Iizuka M
    Scand J Immunol; 1998 Oct; 48(4):364-70. PubMed ID: 9790306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restricted usage of T cell receptor V alpha/J alpha gene segments with different nucleotide but identical amino acid sequences in HLA-DR3+ sarcoidosis patients.
    Grunewald J; Hultman T; Bucht A; Eklund A; Wigzell H
    Mol Med; 1995 Mar; 1(3):287-96. PubMed ID: 8529107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biased TCR gene usage in alloreactive T cells specific for a structurally dissimilar MHC alloantigen.
    George A; Dazzi F; Lynch J; Sidhu S; Marelli F; Batchelor RJ; Lombardi G; Lechler RI
    Int Immunol; 1994 Nov; 6(11):1785-90. PubMed ID: 7865471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule.
    Weyand CM; Hicok KC; Hunder GG; Goronzy JJ
    J Clin Invest; 1992 Dec; 90(6):2355-61. PubMed ID: 1469092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell receptor diversity in alloreactive responses against HLA-B27 (B*2705) is limited by multiple-level restrictions in both alpha and beta chains.
    Barber DF; López D; López de Castro JA
    Eur J Immunol; 1995 Sep; 25(9):2479-85. PubMed ID: 7589114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.
    Ramzaoui S; Jouen-Beades F; Gilbert D; Borsa-Lebas F; Michel Y; Humbert G; Tron F
    Clin Immunol Immunopathol; 1995 Oct; 77(1):33-41. PubMed ID: 7554481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly restricted TCR-alpha beta usage by autoreactive human T cell clones specific for DNA topoisomerase I: recognition of an immunodominant epitope.
    Kuwana M; Medsger TA; Wright TM
    J Immunol; 1997 Jan; 158(1):485-91. PubMed ID: 8977226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.